115 related articles for article (PubMed ID: 37268188)
21. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
[TBL] [Abstract][Full Text] [Related]
22. Survival after reoperation for recurrent glioblastoma multiforme: A prospective study.
Furtak J; Kwiatkowski A; Śledzińska P; Bebyn M; Krajewski S; Szylberg T; Birski M; Druszcz A; Krystkiewicz K; Gasiński P; Harat M
Surg Oncol; 2022 Jun; 42():101771. PubMed ID: 35512545
[TBL] [Abstract][Full Text] [Related]
23. Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.
Sughrue ME; Sheean T; Bonney PA; Maurer AJ; Teo C
Neurosurg Focus; 2015 Mar; 38(3):E11. PubMed ID: 25727220
[TBL] [Abstract][Full Text] [Related]
24. Role of
Brandes AA; Franceschi E; Paccapelo A; Tallini G; De Biase D; Ghimenton C; Danieli D; Zunarelli E; Lanza G; Silini EM; Sturiale C; Volpin L; Servadei F; Talacchi A; Fioravanti A; Pia Foschini M; Bartolini S; Pession A; Ermani M
Oncologist; 2017 Apr; 22(4):432-437. PubMed ID: 28275120
[TBL] [Abstract][Full Text] [Related]
25. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
26. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
Thomas JG; Rao G; Kew Y; Prabhu SS
Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
[TBL] [Abstract][Full Text] [Related]
28. Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.
Nava F; Tramacere I; Fittipaldo A; Bruzzone MG; Dimeco F; Fariselli L; Finocchiaro G; Pollo B; Salmaggi A; Silvani A; Farinotti M; Filippini G
Neuro Oncol; 2014 May; 16(5):719-27. PubMed ID: 24463354
[TBL] [Abstract][Full Text] [Related]
29. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
30. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
[TBL] [Abstract][Full Text] [Related]
31. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
32. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
33. First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia.
Brandes AA; Basso U; Reni M; Vastola F; Tosoni A; Cavallo G; Scopece L; Ferreri AJ; Panucci MG; Monfardini S; Ermani M;
J Clin Oncol; 2004 May; 22(9):1598-604. PubMed ID: 15117981
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice.
Carter TC; Medina-Flores R; Lawler BE
Biomed Res Int; 2018; 2018():6204676. PubMed ID: 30687753
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival.
Burkhardt JK; Riina H; Shin BJ; Christos P; Kesavabhotla K; Hofstetter CP; Tsiouris AJ; Boockvar JA
World Neurosurg; 2012 Jan; 77(1):130-4. PubMed ID: 22405392
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
38. γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
Skeie BS; Enger PØ; Brøgger J; Ganz JC; Thorsen F; Heggdal JI; Pedersen PH
World Neurosurg; 2012 Dec; 78(6):658-69. PubMed ID: 22484078
[TBL] [Abstract][Full Text] [Related]
39. Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature.
Grisanti S; Ferrari VD; Buglione M; Agazzi GM; Liserre R; Poliani L; Buttolo L; Gipponi S; Pedersini R; Consoli F; Panciani P; Roca E; Spena G; Triggiani L; Berruti A;
J Neurosurg Sci; 2019 Aug; 63(4):458-467. PubMed ID: 27680966
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
